Abstract
The introduction of left ventricular assist device (LVAD) has improved survival rates for patients with end-stage heart failure. Survival rate at one year with the latest generation of continuous flow (CF) LVAD now approaches 80%. They have been approved suitable as a destination therapy (DT) in patients who were not eligible for transplantation. As a result, the LVAD population is growing, and the need for noncardiac surgical procedures (NCSs) in these patients will continue to rise. The anesthesiologist needs to be familiar with these particular types of patients and with these devices. The aim of this chapter is to highlight the devices’ characteristics, the LVAD patients’ hemodynamic profile, and the most frequent complications, together with an overview on how to approach these patients when they present for elective or emergency NCS.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, Gheorghiade M. The global health and economic burden of hospitalizations for heart failure: Lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014;63(12):1123–33.
Metra M, Ponikowski P, Dickstein K, McMurray JJV, Gavazzi A, Bergh CH, et al. Advanced chronic heart failure: a position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2007;9(6–7):684–94. https://doi.org/10.1016/j.ejheart.2007.04.003.
Ammirati E, Oliva FG, Colombo T, Russo CF, Cipriani MG, Garascia A, et al. Mid-term survival after continuous-flow left ventricular assist device versus heart transplantation. Heart Vessels. 2016;31(5):722–33. https://doi.org/10.1007/s00380-015-0654-4.
Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim D, Tierney A, et al. Long-Term Use of a Left Ventricular Assist Device. N Engl J Med. 2001;345(20):1435–43.
Kormos RL, Cowger J, Pagani FD, Teuteberg JJ, Goldstein DJ, Jacobs JP, et al. The Society of Thoracic Surgeons Intermacs database annual report: evolving indications, outcomes, and scientific partnerships. J Heart Lung Transplant. 2019;38(2):114–26. https://doi.org/10.1016/j.healun.2018.11.013.
Molina EJ, Shah P, Kiernan MS, Cornwell WK, Copeland H, Takeda K, et al. The Society of Thoracic Surgeons Intermacs 2020 annual report. Ann Thorac Surg. 2021;111(3):778–92. https://doi.org/10.1016/j.athoracsur.2020.12.038.
Morgan JA, Paone G, Nemeh HW, Henry SE, Gerlach B, Williams CT, et al. Non-cardiac surgery in patients on long-term left ventricular assist device support. J Heart Lung Transplant. 2012;31(7):757–63. https://doi.org/10.1016/j.healun.2012.02.023. Left Ventricular Assist Devices
Vaidya Y, Riaz S, Dhamoon AS. Left ventricular assist devices. Treasure Island (FL): StatPearls Publishing; 2021. https://www.ncbi.nlm.nih.gov/books/NBK499841/?report
Miller LW, Rogers JG. Evolution of left ventricular assist device therapy for advanced heart failure: a review. JAMA Cardiol. 2018;3(7):650–8. https://doi.org/10.1001/jamacardio.2018.0522.
Potapov EV, Antonides C, Crespo-Leiro MG, Combes A, Färber G, Hannan MM, et al. 2019 EACTS Expert Consensus on long-term mechanical circulatory support. Eur J Cardiothorac Surg. 2019;56(2):230–70. https://doi.org/10.1093/ejcts/ezz098.
Kuehl M, Garbade J. The evolution of left ventricular assist devices—a moment to reflect. J Thorac Dis. 2017;9(5):E492–4. https://doi.org/10.21037/jtd.2017.03.72.
Mehra MR, Uriel N, Naka Y, Cleveland JC, Yuzefpolskaya M, Salerno CT, et al. A fully magnetically levitated left ventricular assist device—final report. N Engl J Med. 2019;380(17):1618–27. https://doi.org/10.1056/nejmoa1900486.
Lim HS, Howell N, Ranasinghe A. The physiology of continuous-flow left ventricular assist devices. J Card Fail. 2017;23(2):169–80. https://doi.org/10.1016/j.cardfail.2016.10.015.
Paprotny M, Ruschitzka F, Lüders B, Wilhelm MJ, Aser R, Bettex D, et al. Pulsatile arterial blood pressure mimicking aortic valve opening during continuous-flow LVAD support: a case report. J Cardiothorac Surg. 2019;14(1):1–4. https://doi.org/10.1186/s13019-019-1039-z.
Dalia AA, Cronin B, Stone ME, Turner K, Hargrave J, Vidal Melo MF, Essandoh M. Anesthetic management of patients with continuous-flow left ventricular assist devices undergoing noncardiac surgery: an update for anesthesiologists. J Cardiothorac Vasc Anesth. 2018;32(2):1001–12. https://doi.org/10.1053/j.jvca.2017.11.038.
Patel SR, Madan S, Saeed O, Algodi M, Luke A, Gibber M, et al. Association of nasal mucosal vascular alterations, gastrointestinal arteriovenous malformations, and bleeding in patients with continuous-flow left ventricular assist devices. JACC Heart Failure. 2016;4(12):962–70. https://doi.org/10.1016/j.jchf.2016.08.005.
Feldman D, Pamboukian SV, Teuteberg JJ, Birks E, Lietz K, Moore SA, et al. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: Executive summary. J Heart Lung Transplant. 2013;32(2):157–87. https://doi.org/10.1016/j.healun.2012.09.013.
Vader JM, Ewald GA, Gage BF. Relationship between anticoagulation intensity and thrombotic or bleeding outcomes amongst. 2017;9(5):1–19. Ventricular Assist Devices. Circ Heart Fail. 2016;9(5):e002680. https://doi.org/10.1161/CIRCHEARTFAILURE.115.002680. https://doi.org/10.1161/CIRCHEARTFAILURE.115.002680.RELATIONSHIP
Inamullah O, Chiang YP, Bishawi M, Weiss M, Lutz MW, Blue LJ, et al. Characteristics of strokes associated with centrifugal flow left ventricular assist devices. Sci Rep. 2021;11(1):1–9. https://doi.org/10.1038/s41598-021-81445-8.
Mathis M. Complications, risk factors, and staffing patterns for noncardiac surgery in patients with left ventricular assist devices. Anesthesiology. 2017;126(3):450–60. https://doi.org/10.1097/ALN.0000000000001488.
Kettyle SM, Chervu NL, Rao AS, Sadi S, Majure D, Sava JA, Johnson LS. Outcomes following noncardiac surgery in patients with ventricular assist devices: a single-center experience. Am Surg. 2017;83(8):842–6. https://doi.org/10.1177/000313481708300833.
Bauman ZM, Cunningham R, Hodson A, Shostrom V, Evans CH, Schlitzkus LL. Emergent general surgery operations in patients with left ventricular assist devices. Am Surg. 2021;87:8–14. https://doi.org/10.1177/0003134820950683.
Davis J, Sanford D, Schilling J, Hardi A, Colditz G. Systematic review of outcomes after noncardiac surgery in patients with implanted left ventricular assist devices. ASAIO J. 2015;61(6):648–51. https://doi.org/10.1097/MAT.0000000000000278.
Taghavi S, Jayarajan SN, Ambur V, Mangi AA, Chan E, Dauer E, et al. Noncardiac surgical procedures after left ventricular assist device implantation. ASAIO J. 2016;62(4):370–4. https://doi.org/10.1097/MAT.0000000000000366.
Mentias A, Briasoulis A, Vaughan Sarrazin MS, Alvarez PA. Trends, perioperative adverse events, and survival of patients with left ventricular assist devices undergoing noncardiac surgery. JAMA Netw Open. 2020;3(11):1–11. https://doi.org/10.1001/jamanetworkopen.2020.25118.
Vigneswaran Y, Wang V, Krezalek M, Prachand V, Wyers S, Juricek C, et al. Laparoscopic procedures in patients with cardiac ventricular assist devices. Surg Endosc. 2019;33(7):2181–6. https://doi.org/10.1007/s00464-018-6497-1.
Moazami N, Fukamachi K, Kobayashi M, Smedira NG, Hoercher KJ, Massiello A, et al. Axial and centrifugal continuous-flow rotary pumps: a translation from pump mechanics to clinical practice. J Heart Lung Transplant. 2013;32(1):1–11. https://doi.org/10.1016/j.healun.2012.10.001.
Lampert BC, Teuteberg JJ. Right ventricular failure after left ventricular assist devices. J Heart Lung Transplant. 2015;34(9):1123–30. https://doi.org/10.1016/j.healun.2015.06.015.
Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED, et al. Sixth INTERMACS annual report: a 10,000-patient database. J Heart Lung Transplant. 2014;33(6):555–64.
Rosenman DJ, McDonald FS, Ebbert JO, Erwin PJ, LaBella M, Montori VM. Clinical consequences of withholding versus administering renin-angiotensin-aldosterone system antagonists in the preoperative period. J Hosp Med. 2008;3(4):319–25. https://doi.org/10.1002/jhm.323.
Kristensen SD, Knuuti J, Saraste A, Anker S, Bøtker HE, De Hert S, et al. 2014 ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management: the joint task force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014;35(35):2383–431. https://doi.org/10.1093/eurheartj/ehu282.
El-Magharbel I. Ventricular assist devices and anesthesia. Semin Cardiothorac Vasc Anesth. 2005;9(3):241–9. https://doi.org/10.1177/108925320500900306.
Stoicea N, Sacchet-Cardozo F, Joseph N, Kilic A, Sipes A, Essandoh M. Pro: cardiothoracic anesthesiologists should provide anesthetic care for patients with ventricular assist devices undergoing noncardiac surgery. J Cardiothorac Vasc Anesth. 2017;31(1):378–81. https://doi.org/10.1053/j.jvca.2016.06.030.
Rich JD, Burkhoff D. HVAD flow waveform morphologies: theoretical foundation and implications for clinical practice. ASAIO J. 2017;63(5):526–35. https://doi.org/10.1097/MAT.0000000000000557.
Ficke DJ, Lee J, Chaney MA, Bas H, Vidal-Melo MF, Stone ME. Case 62010 noncardiac surgery in patients with a left ventricular assist device. J Cardiothorac Vasc Anesth. 2010;24(6):1002–9. https://doi.org/10.1053/j.jvca.2010.09.005.
Slaughter MS, Pagani FD, Rogers JG, Miller LW, Sun B, Russell SD, et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29(4 SUPPL):S1–S39. https://doi.org/10.1016/j.healun.2010.01.011.
Essandoh M, Shabsigh M, Turner M, Otey A, Poulton C, Fiorda-Diaz J, Kilic A. Heartmate II inflow path thrombosis: emphasis on a comprehensive approach to diagnosis. J Cardiothorac Vasc Anesth. 2017;31(3):1015–20. https://doi.org/10.1053/j.jvca.2016.08.005.
Barbara DW, Wetzel DR, Pulido JN, Pershing BS, Park SJ, Stulak JM, et al. The perioperative management of patients with left ventricular assist devices undergoing noncardiac surgery. Mayo Clin Proc. 2013;88(7):674–82. https://doi.org/10.1016/j.mayocp.2013.03.019.
Peberdy MA, Gluck JA, Ornato JP, Bermudez CA, Griffin RE, Kasirajan V, et al. Cardiopulmonary resuscitation in adults and children with mechanical circulatory support: a scientific statement from the American Heart Association. Circulation. 2017;135(24):e1115–34. https://doi.org/10.1161/CIR.0000000000000504.
Aissaoui N, Jouan J, Gourjault M, Diebold B, Ortuno S, Hamdan A, et al. Understanding left ventricular assist devices. Blood Purif. 2018;46(4):292–300. https://doi.org/10.1159/000491872.
Kamboj M, Kazory A. Left ventricular assist device and the kidney: getting to the heart of the matter. Blood Purif. 2019;48(4):289–98. https://doi.org/10.1159/000502080.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mondino, M.G., Paradiso, E., Nonini, S. (2023). Evaluation and Management of Patients with Left Ventricular Assist Device (LVAD) Requiring Noncardiac SurgicalProcedures. In: Aseni, P., Grande, A.M., Leppäniemi, A., Chiara, O. (eds) The High-risk Surgical Patient. Springer, Cham. https://doi.org/10.1007/978-3-031-17273-1_37
Download citation
DOI: https://doi.org/10.1007/978-3-031-17273-1_37
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-17272-4
Online ISBN: 978-3-031-17273-1
eBook Packages: MedicineMedicine (R0)